Prognostic value of a three-grade classification in primary epithelial parotid carcinoma: Result of a histological review from a 20-year experience of total parotidectomy with neck dissection in a single institution

European Journal of Cancer

Volumn 46, Issue 2, 2010, Pages 323-331

  Jouzdani, Elham ^a   Yachouh, Jacques ^b   Costes, Valérie ^a   Faillie, Jean Luc ^c   Cartier, César ^a   Poizat, Flora ^a   Pierre, Guillemette ^a   Burcia, Vincent ^a   Makeieff, Marc ^a   Crampette, Louis ^a   Guerrier, Bernard ^a   Garrel, Renaud ^a  

^a GUI DE CHAULIAC HOSPITAL   (France)

^b LAPEYRONIE HOSPITAL   (France)

^c HÔPITAL ARNAUD DE VILLENEUVE   (France)

Author keywords

Parotid cancer; Prognostic factor; Surgery; TNM classification; Tumour grading

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER GRADING; CANCER INVASION; CANCER STAGING; CANCER SURVIVAL; CHILD; EPITHELIAL PAROTID CARCINOMA; FACIAL NERVE; FACIAL NERVE PARALYSIS; FEMALE; HARDNESS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PAROTID GLAND CARCINOMA; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SCHOOL CHILD; SURVIVAL RATE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; FEMALE; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NECK DISSECTION; NEOPLASM STAGING; PAROTID GLAND; PAROTID NEOPLASMS; POSTOPERATIVE CARE; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 72449131507     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2009.10.012     Document Type: Article

References (22)

1. Ries L, Harkins D, Krapcho M, et al., editors. SEER cancer statistics review, 1975-2003, National Cancer Institute. Bethesda, MD. , based on November 2005 SEER data submission, posted to the SEER web site; 2006 [In: Cancer S, editor.; 2006].
2. Pinkston J.A., and Cole P. Incidence rates of salivary gland tumors: results from a population-based study. Otolaryngol Head Neck Surg 120 (1999) 834-840
3. Ostman J., Anneroth G., Gustafsson H., and Tavelin B. Malignant salivary gland tumours in Sweden 1960-1989-an epidemiological study. Oral Oncol 33 (1997) 169-176
4. Nagler R.M., and Laufer D. Tumors of the major and minor salivary glands: review of 25 years of experience. Anticancer Res 17 (1997) 701-707
5. Spiro R.H. Salivary neoplasms: overview of a 35-year experience with 2,807 patients. Head Neck Surg 8 (1986) 177-184
6. Bensadoun R.J., Blanc-Vincent M.P., Chauvel P., et al. Malignant tumours of the salivary glands. Br J Cancer 84 Suppl. 2 (2001) 42-48
7. Godballe C., Schultz J.H., Krogdahl A., Moller-Grontved A., and Johansen J. Parotid carcinoma: impact of clinical factors on prognosis in a histologically revised series. Laryngoscope 113 (2003) 1411-1417
8. Barnes L., Evenson J., Reichart P., and Sidransky D. Pathology and genetics head and neck tumours. World Health Organisation classification of tumours. 3rd ed. (2005), IARC 212-281
9. Sobin L.H., and Wittekind C. TNM classification of malignant tumours. 6th ed. (2002), Wiley-Liss, New York
10. Therkildsen M.H., Christensen M., Andersen L.J., Schiodt T., and Hansen H.S. Salivary gland carcinomas-prognostic factors. Acta Oncol 37 (1998) 701-713
11. Klussmann J.P., Ponert T., Mueller R.P., Dienes H.P., and Guntinas-Lichius O. Patterns of lymph node spread and its influence on outcome in resectable parotid cancer. Eur J Surg Oncol 34 (2008) 932-937
12. van der Wal J.E., Becking A.G., Snow G.B., and van der Waal I. Distant metastases of adenoid cystic carcinoma of the salivary glands and the value of diagnostic examinations during follow-up. Head Neck 24 (2002) 779-783
13. Armstrong J.G., Harrison L.B., Thaler H.T., et al. The indications for elective treatment of the neck in cancer of the major salivary glands. Cancer 69 (1992) 615-619
14. Kane W.J., McCaffrey T.V., Olsen K.D., and Lewis J.E. Primary parotid malignancies. A clinical and pathologic review. Arch Otolaryngol Head Neck Surg 117 (1991) 307-315
15. Moore B.A., Weber R.S., Prieto V., et al. Lymph node metastases from cutaneous squamous cell carcinoma of the head and neck. Laryngoscope 115 (2005) 1561-1567
16. Flynn M.B., Maguire S., Martinez S., and Tesmer T. Primary squamous cell carcinoma of the parotid gland: the importance of correct histological diagnosis. Ann Surg Oncol 6 (1999) 768-770
17. Zbaren P., Nuyens M., Loosli H., and Stauffer E. Diagnostic accuracy of fine-needle aspiration cytology and frozen section in primary parotid carcinoma. Cancer 100 (2004) 1876-1883
18. Zbaren P., Tschumi I., Nuyens M., and Stauffer E. Recurrent pleomorphic adenoma of the parotid gland. Am J Surg 189 (2005) 203-207
19. Brandwein M.S., Ivanov K., Wallace D.I., et al. Mucoepidermoid carcinoma: a clinicopathologic study of 80 patients with special reference to histological grading. Am J Surg Pathol 25 (2001) 835-845
20. Norberg-Spaak L., Dardick I., and Ledin T. Adenoid cystic carcinoma: use of cell proliferation, BCL-2 expression, histologic grade, and clinical stage as predictors of clinical outcome. Head Neck 22 (2000) 489-497
21. Gomez D.R., Katabi N., Zhung J., et al. Clinical and pathologic prognostic features in acinic cell carcinoma of the parotid gland. Cancer 115 (2009) 2128-2137
22. Vander Poorten V.L., Hart A., Vauterin T., et al. Prognostic index for patients with parotid carcinoma: international external validation in a Belgian-German database. Cancer 115 (2009) 540-550